Current scenario on non-nucleoside reverse transcriptase inhibitors (2018-present) - ScienceDirect

Chemical diversity and activity profiles of HIV-1 reverse

The Architecture of SARS-CoV-2 Transcriptome - ScienceDirect

Non-Nucleoside Reverse Transcriptase Inhibitors - an overview

Current scenario on non-nucleoside reverse transcriptase

Current scenario on non-nucleoside reverse transcriptase

Pharmaceuticals, Free Full-Text

p53 and p53-related mediators PAI-1 and IGFBP-3 are downregulated

Development of a multiassay algorithm (MAA) to identify recent HIV

Approved HIV reverse transcriptase inhibitors in the past decade